| Primary |
| Osteoarthritis |
66.7% |
| Arthralgia |
33.3% |
|
| Blood Pressure Increased |
20.0% |
| No Adverse Event |
20.0% |
| Pruritus |
20.0% |
| Respiratory Arrest |
20.0% |
| Systemic Inflammatory Response Syndrome |
20.0% |
|
| Secondary |
| Cataract Operation |
29.8% |
| Drug Use For Unknown Indication |
11.4% |
| Preoperative Care |
11.2% |
| Postoperative Care |
5.1% |
| Eye Irrigation |
4.7% |
| Perioperative Analgesia |
4.0% |
| Arthralgia |
3.8% |
| Cycloplegia |
3.4% |
| Local Anaesthesia |
3.1% |
| Constipation |
2.9% |
| Infection |
2.9% |
| Pyrexia |
2.9% |
| Medication Dilution |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Mydriasis |
2.2% |
| Musculoskeletal Pain |
2.0% |
| Anaesthesia |
1.6% |
| Eye Operation |
1.3% |
| Osteoarthritis |
1.3% |
| Prophylaxis |
0.9% |
|
| Toxic Anterior Segment Syndrome |
30.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
20.8% |
| Visual Acuity Reduced |
9.4% |
| Corneal Abrasion |
7.5% |
| Rash Generalised |
7.5% |
| Sudden Death |
5.7% |
| Incorrect Route Of Drug Administration |
3.8% |
| Retinal Injury |
3.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.9% |
| Intraocular Pressure Increased |
1.9% |
| Lymphocyte Stimulation Test Positive |
1.9% |
| Macular Degeneration |
1.9% |
| Myocardial Infarction |
1.9% |
| Retinal Disorder |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.5% |
| Rheumatoid Arthritis |
15.2% |
| Drug Use For Unknown Indication |
7.2% |
| Breast Cancer |
5.4% |
| Insomnia |
5.3% |
| Constipation |
3.3% |
| Neoplasm Malignant |
3.3% |
| Osteoarthritis |
3.3% |
| Hypertension |
2.6% |
| Infection Prophylaxis |
2.6% |
| Prophylaxis |
2.6% |
| Prophylaxis Against Graft Versus Host Disease |
2.4% |
| Adverse Event |
2.3% |
| Dysthymic Disorder |
2.0% |
| Back Pain |
1.8% |
| Macular Degeneration |
1.8% |
| Postoperative Care |
1.8% |
| Osteoporosis |
1.7% |
| Dry Eye |
1.5% |
| Gastritis |
1.5% |
|
| Weight Increased |
10.6% |
| Diverticulitis Intestinal Haemorrhagic |
9.4% |
| Ocular Hyperaemia |
7.1% |
| Vomiting |
7.1% |
| Pericardial Effusion |
5.9% |
| Wound Infection |
5.9% |
| Hypersensitivity |
4.7% |
| Sepsis |
4.7% |
| Septic Shock |
4.7% |
| Stomatitis |
4.7% |
| Toxic Anterior Segment Syndrome |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Angina Pectoris |
3.5% |
| Paralysis |
3.5% |
| Pneumonia |
3.5% |
| Urticaria |
3.5% |
| Uveitis |
3.5% |
| Vocal Cord Paralysis |
3.5% |
| Abdominal Distension |
2.4% |
| Anaphylactic Shock |
2.4% |
|
